semaglutide health risks Who Should Consider GLP-1? Semaglutide GLP-1 is generally recommended for individuals with type 2 diabetes who have not achieved adequate blood sugar control with other medications such as metformin, or for Recent study at UC Irvine

VICTOZA (liraglutide) prescribing information

These include whether an individual has diabetes along with obesity, and whether their plan lists Ozempic on its list of approved drugs

Most of the gray market buyers Reuters interviewed had told their medical providers they were taking GLP-1 medicines but not where or how they bought them

Although it is often thought of as a diabetes drug, Ozempic is often prescribed off-label for weight loss, but it is not FDA approved for this use

(Photo illustration by Scott Olson/Getty Images) The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment